Abstract
Novel peptides and the uses thereof, in particular for use in male contraception or for use in the treatment of male infertility.
Claims
- A peptide comprising or consisting of the following amino acid sequence: H-GQQDQDRKVICFVAVSTLNV-NH2.
- A peptide comprising or consisting of the following amino acid sequence: H-KPNATRPVTPPRVASGLNPSIQKASNYRNNTVLY-NH2.
- A peptide according to claim 1 or 2, wherein the peptide comprises a cell- penetrating peptide.
- A peptide according to any one of claims 1 to 3, wherein the cell-penetrating peptide is selected from the group consisting of penetratin (RQIK1WFQNRRMKWKK), HIV-derived tat
- (GRKKRRQRRRPQRNYF), transportan 10 (AGYLLGKINLKALAALAKKI). C105Y (CSIPPEVKF KPFVYLI), mitoparan (INLKKLAKL(Aib)KKIL), nosangiotide (RKKTFKEVANAVKISA), cytochrome C5"13 (KGKKIFIMK).
- A peptide according to claim 4, wherein the cell-penetrating peptide is penetratin.
- A peptide according to any one of claims 1 to 5, wherein the peptide further comprises a PIP binding site motif. 7. A peptide according to claim 6, wherein the PIP binding motif is selected
- from the group consisting of PPP1CC2 C-terminus, K-P-N-A-T-R-P- V-T- P-P-R-V-A-S-G-L-N-P-S-I-Q-K-A-S-N-Y-R-N-N-T-V-L-Y; AKAP4[7], G- Q-Q-D-Q-D-R-K-V-I-C-F-V-D-V-S-T-L-N-V, K-V-I-C-F; RVxFil8!, [RK]- X(0.1)-|VI|-«P!-|FW]. I II K R I - [ A C II K M NQRST V | - V - 1 C HKNQRST|-|FW|. [KRL]-[KRSTAMVHNQJ-[V6J-{FIMYDP}-[FWJ; SILK18', K-[GS]-I-L- K,
- [GS]-I-L-[RK]; PPP1R2 degenerate'2"5, R-[KR]-X-H-Y; iASPP degenerate1215, R-N-Y-F; MyphoNE[19], R-X-X-Q-| V I L | -| K R |-X-| Y W | ; Apoptotic signature122 ', F-X-X-[ Rk |-X-| RK|. Apoptotic signature with juxtaposed RVxF[23], [RK]-X(0,1)-[VI]-X-F-X-X-[RK]-X-[RKJ; GADD34[24], R-A-R-A; and SpiDoc[25], Y-S-N-E-D-Y-D-R. 8 A peptide according to any one of claims 1 to 7, for use in increasing or decreasing sperm motility by modulation of the phosphoprotein phosphatase 1 complexes.
- A peptide according to any one of claims 1 to 7, for use in modulating phosphoprotein phosphatase 1 complexes.
- A peptide according to any one of claims 1 to 7, for use in modulating sperm motility.
- A peptide according to any one of claims 1 to 7, for use in the treatment of male infertility.
- A method of treating male infertility comprising administering to a subject in need thereof a therapeutically effective amount of the peptide according to any one of claims 1 to 7.
- A method of providing contraception, comprising administering an effective amount of a peptide according to any one of claims 1 to 7 to a subject in need of male contraception.
- A pharmaceutical composition comprising a peptide according to any one of claims 1 to 7 and a pharmaceutically acceptable carrier.
Applicants
-
Univ Of Wolverhampton
Explore more patents:
-
Univ Aveiro
Explore more patents:
Inventors
-
Fardilha Margarida Sâncio Da Cruz
Explore more patents:
-
Vieira Da Silva Joana
Explore more patents:
-
Freitas Maria João
Explore more patents:
-
Howl John
Explore more patents:
-
Jones Sarah
Explore more patents:
CPC Classifications
-
F04B49/06
Explore more patents:
-
A61K38/00
Explore more patents:
-
A61P15/00
Explore more patents:
-
C07K2319/10
Explore more patents:
-
C07K2319/70
Explore more patents:
-
C12N9/16
Explore more patents:
-
C12Y301/03016
Explore more patents:
-
F04B2203/0209
Explore more patents:
-
F04D15/0066
Explore more patents:
-
F05D2260/85
Explore more patents:
IPC Classifications
-
C07K14/435
Explore more patents:
-
A61K38/00
Explore more patents:
-
A61P15/00
Explore more patents:
Download PDF
Document Preview
Document History
- Publication: Jan 24, 2019
-
Application:
Jul 19, 2018
GB 2018052046 W
-
Priority:
Jul 19, 2017
GB 201711620 A